# Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

> **NCT06082063** · PHASE3 · RECRUITING · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 2000 (estimated)

## Conditions studied

- Cardiovascular Diseases
- Heart Failure
- Type 1 Diabetes
- Kidney Failure

## Interventions

- **DRUG:** Aspirin tablet
- **DRUG:** Semaglutide
- **DRUG:** Sotagliflozin
- **DRUG:** Finerenone

## Key facts

- **NCT ID:** NCT06082063
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-01
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2025-01-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06082063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06082063, "Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06082063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*